Is amisulpride an 'atypical'atypical antipsychotic agent?LECRUBIER, Yves.International clinical psychopharmacology. 2000, Vol 15, pp S21-S26, issn 0268-1315, SUP4Conference Paper

Physical components of depression and psychomotor retardationLECRUBIER, Yves.The Journal of clinical psychiatry. 2006, Vol 67, pp 23-26, issn 0160-6689, 4 p., SUP6Article

Le métier de chercheur en psychiatrie en 1994 = The researcher's job in psychiatry, in 1994LECRUBIER, Y.Perspectives psychiatriques (Paris). 1993, Vol 32-33, Num 40, pp 340-342, issn 0031-6032Article

The influence of comorbidity on the prevalence of suicidal behaviourLECRUBIER, Y.European psychiatry. 2001, Vol 16, Num 7, pp 395-399, issn 0924-9338Article

Widespread underrecognition and undertreatment of anxiety and mood disorders : Results from 3 European studiesLECRUBIER, Yves.The Journal of clinical psychiatry. Supplement. 2007, Vol 68, Num 2, pp 36-41, 6 p.Conference Paper

Changing Management of Schizophrenia: What do Atypical Antipsychotics Achieve?LECRUBIER, Yves.International clinical psychopharmacology. 2000, Vol 15, issn 0268-1315, 28 p., SUP4Conference Proceedings

Stress and quality of life = Stress and quality of lifeLECRUBIER, Y.European psychiatry. 2005, Vol 20, issn 0924-9338, 29 p., SUP3Serial Issue

Amisulpride: Progress and outcomesLECRUBIER, Y.Current medical research and opinion. Supplement. 2002, Vol 18, Num 3, pp S18-S22, issn 0141-9951Conference Paper

Pharmacological interventions in dysthymiaLECRUBIER, Y.European psychiatry. 1996, Vol 11, pp 129s-133s, issn 0924-9338, SUP3Conference Paper

Médecine générale : un quart de problèmes psychologiques = General medicine: one fourth of psychological problemsLECRUBIER, Y.Gazette médicale (Paris). 1995, Vol 102, Num 34, pp 33-34, issn 0760-758XArticle

Doit-on envisager une classification des neuroleptiques tenant mieux compte des mécanismes d'action et des différents syndromes cible? = Multiple pharmacological mechanisms and clinical targets for neuroleptics: Should a more operational classification be considered?LECRUBIER, Y.Psychiatrie & psychobiologie. 1987, Vol 2, Num 4, pp 232-238, issn 0767-399XArticle

La chimiothérapie à l'adolescence = Chemotherapy in adolescentsLECRUBIER, Y.La Semaine des hôpitaux de Paris. 1986, Vol 62, Num 27, pp 2103-2105, issn 0037-1777Article

Traitement des subsyndromes, ou : qu'attendre d'une chimiothérapie des états dépressifs subsyndromiques = Treatment of subsyndrome, or : what can one wait for a chemotherapy of subsyndromal depressive statesLECRUBIER, Y.L' Encéphale (Paris). 1994, Vol 20, pp 265-266, issn 0013-7006, NS2Conference Paper

Risk-benefit assessment of newer versus older monoamine oxidase (MAO) inhibitorsLECRUBIER, Y.Drug safety. 1994, Vol 10, Num 4, pp 292-300, issn 0114-5916Article

Schizophrénie: La prescription des neuroleptiques antiproductifs et antidéficitaires en France = Schizophrenia: the prescription of neuroleptics in France according to the presence of positive or negative symptomsLECRUBIER, Y.Psychiatrie & psychobiologie. 1986, Vol 1, Num 2, pp 139-147, issn 0767-399XArticle

Atypical antipsychotic drugs in dysthymia : placebo controlled studies of amisulpride versus imipramine, versus amineptineBOYER, P; LECRUBIER, Y.European psychiatry. 1996, Vol 11, pp 135s-140s, issn 0924-9338, SUP3Conference Paper

The place of the SSRIs and fluvoxamine in the treatment of patients with depressionLECRUBIER, Y.Drugs (Basel). 1992, Vol 43, pp 1-2, issn 0012-6667, SUP2Conference Paper

Panic and depression : a worldwide primary care perspectiveLECRUBIER, Y; ÜSTÜN, T. B.International clinical psychopharmacology. 1998, Vol 13, pp S7-S11, issn 0268-1315, SUP4Conference Paper

Long-term phase of schizophrenia: Impact of atypical agentsNABER, Dieter.International clinical psychopharmacology. 2000, Vol 15, pp S11-S14, issn 0268-1315, SUP4Conference Paper

Evolution clinique des troubles dépressifs : Implications thérapeutiques = Clinical course of depresive disorders : Therapeutic implicationsHERGUETA, T; LECRUBIER, Y.Neuro-psy. 1998, Vol 13, Num 3, pp 118-125, issn 0296-3981Article

Pharmacotherapy of dysthymia: recent perspectivesLECRUBIER, Y; SMERALDI, E.European psychiatry. 1996, Vol 11, issn 0924-9338, 111s-147s [39 p.], SUP3Conference Proceedings

Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depressionLECRUBIER, Y; GUELFI, J. D.Acta psychiatrica scandinavica. Supplementum. 1990, Vol 82, Num 360, pp 18-23, issn 0065-1591, 6 p.Conference Paper

Stress : the shared common component in major mental illnessesDINAN, T. G.European psychiatry. 2005, Vol 20, pp S326-S328, issn 0924-9338, SUP3Article

Effets pro-activateurs plaquettaires des pansements alginates: Etude in vitro de l'alginate 100 % (Algosteril®) et de l'alginate-carboxymethylcellulose (Urgosorb®) sur les fonctions des plaquettes humaines = Platelets proactivation of alginate dressings. Study in vitroELALAMY, I; LECRUBIER, C.JPC. Journal des plaies et cicatrisations. 2001, Num 28, pp 18-21, issn 1268-8924Article

Schizophrénie, de la nosographie à la dimensionnalité : importance des données longitudinales = Schizophrenia, from disease classification to different dimensions : the importance of longitudinal dataLECRUBIER, Y.L' Encéphale (Paris). 1997, Vol 23, pp 39-43, issn 0013-7006, NS2Article